Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04947605

Epidemiological Landscape of Cervical Cancer in Latin America

A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Uterine Cervical Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Diseases Uterine Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

A Real e Benemérita Associação Portuguesa de Beneficência

São Paulo, 01323-001, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women > 18 years.
  • Histologically proven cervical carcinoma
  • Diagnosis of carcinoma of the cervix since January 2018 or newly diagnosis or recurrent disease during the period of study recruitment.
  • Any histology of cervical cancer at time of diagnosis.
  • FIGO stage IB2-IVA
  • Have available and adequate medical records for data collection
  • Accept to participate in the project and sign the informed consent (if applicable)

Exclusion criteria

  • FIGO stage I and IB1
  • Non-invasive cervical cancer
  • Synchronous tumor or second primary tumor in the last five years (exception for thyroid cancer or skin cancer non melanoma)

Treatment and study plan

Primary outcomes

  1. - Summarize the histologic subtype

    Time frame: January of 2028

    Summarize the histologic subtype, assessed by the anatomopathological assay of the tumor sample and the stage at diagnosis, assessed by FIGO stage (International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri - 2018), using gynecological exam. Image studies and TNM stage (AJCC 8th edition) will also be used to assess stage at diagnosis when available.

Sponsors and collaborators

Lead sponsor

Latin American Cooperative Oncology Group

Other

Collaborators

  • Roche Pharma AG

Registry information

Official study title

Epidemiological Landscape of Cervical Cancer in Latin America .

Acronym: EVITA LATAM

Important dates

Study start
2021
Primary completion
2023
Study completion
2028
First posted
Jul 1, 2021
Registry last updated
Jul 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.